Spermidine POLYCAD Trial Completing August 2026: Autophagy Activation and Aging

POLYCAD, a randomized double-blind trial evaluating high-dose spermidine in elderly coronary artery disease (CAD) patients, completes in August 2026. Started in January 2024, the trial assesses spermidine’s effect on cardiac remodeling, exercise capacity, muscle mass, and systemic inflammation.

What is spermidine

Spermidine is a polyamine present in all living cells. Dietary sources include fermented foods (natto, fermented soybean paste), wheat germ, soybeans, mushrooms, and aged cheese.

Spermidine’s most-studied mechanism is autophagy induction. Autophagy is the process where cells clear and recycle damaged proteins and organelles. Its efficiency declines with age, making damage accumulation a core driver of aging.

Nature Cell Biology 2024 finding

A 2024 Nature Cell Biology paper showed spermidine is essential for fasting’s autophagy induction. Spermidine levels rise during fasting or caloric restriction in yeast, flies, mice, and humans. This rise is the central mediator of autophagy and lifespan extension.

The mechanism: fasting increases spermidine synthesis. Spermidine drives hypusination (a specific modification) of the translation regulator eIF5A. Modified eIF5A favors translation of TFEB, the master regulator of autophagy. Autophagy activates.

The implication is twofold. The molecular mechanism behind fasting’s effects is now mapped. And spermidine supplementation may partially mimic some fasting effects without fasting.

POLYCAD design

POLYCAD is conducted in Denmark. Elderly CAD patients are randomized to high-dose spermidine vs placebo.

Four endpoints.

Cardiac remodeling: MRI ventricular structural changes.

Exercise capacity: VO2max, 6-minute walk test.

Muscle mass: DEXA for sarcopenia changes.

Systemic inflammation: CRP, IL-6 and other inflammatory markers.

The trial’s significance: one of the first large-scale RCTs evaluating spermidine’s multi-target effects in humans simultaneously. Until now, spermidine research has relied largely on animal models and observational studies.

Other spermidine trials

A 2018 Nutrients observational study showed populations with higher dietary spermidine had lower mortality. Observational data cannot prove causation.

Smaller RCTs in the early 2020s reported cognitive function improvement and hair growth effects, but with small sample sizes. POLYCAD is the next step toward causal validation.

Compared to other autophagy activators

Other molecules studied as autophagy activators.

Rapamycin: mTOR inhibitor, strongest autophagy activation. Side effects include immune suppression. Prescription drug. One study suggests rapamycin’s autophagy effect itself may operate via increased spermidine synthesis as an indirect path.

Metformin: Activates AMPK and partially stimulates autophagy. Diabetes drug.

Urolithin A: Activates mitophagy (mitochondrion-specific autophagy). The mechanism reported by Lancôme x Timeline.

Spermidine is differentiated by being available through food and having a relatively low side effect profile.

Spermidine supplements

Commercial spermidine supplements (mostly wheat germ extract) typically contain 1-3 mg/day. Doses used in clinical trials including POLYCAD may be higher (specific doses not yet published).

Side effects are typically mild, with GI discomfort most common. Long-term safety data is still limited.

Relationship to fasting

If spermidine is a central mediator of fasting effects, how does spermidine supplementation differ from fasting?

Fasting doesn’t only raise spermidine. It also drops insulin, raises ketones, shifts growth hormone, and triggers wide metabolic changes. The combined effect underlies fasting’s benefits.

Spermidine supplementation activates one segment of that pathway: autophagy. It partially mimics some fasting effects but does not replace fasting completely.

Daily guide

Increasing dietary spermidine is a reasonable first step. Fermented foods (natto contains roughly 5 mg per 100 g; cheonggukjang is richer), wheat germ, fava beans, mushrooms, and aged cheese are rich sources.

Supplements lack a settled standard until POLYCAD results. For autophagy benefit, fasting, exercise, and adequate sleep remain the validated, more powerful interventions, with diet as the foundation.

In this quarter’s aging mechanism matrix, spermidine sits at the autophagy-targeting position. Alongside mitochondria targeting (Urolithin A, NMN), senescent cell targeting (D+Q), and neuromuscular targeting (K2), it forms one axis of a differentiated matrix.